Nvidia, AMD to pay 15% of China chip sales revenue to US govt- FT
Investing.com - Goldman Sachs reduced its price target on Lantheus Holdings (NASDAQ:LNTH) to $110.00 from $140.00 on Thursday, while maintaining a Buy rating on the stock. According to InvestingPro data, the stock is currently trading below its Fair Value, with analyst targets ranging from $70 to $159.
The downward revision follows Lantheus’s second-quarter revenue miss and approximately 10% reduction in fiscal year 2025 guidance, which was lowered to a range of $1,475 million to $1,510 million from the previous $1,550 million to $1,585 million. Despite recent challenges, the company maintains strong financials with a current ratio of 4.29 and moderate debt levels.
Goldman Sachs attributed Pylarify’s underperformance in the second quarter of 2025 to negative impacts on net price, an issue that may continue to concern investors in the near term.
Despite the price target reduction, Goldman Sachs remains optimistic about Lantheus shares at current levels, though it acknowledges that stock appreciation depends on more consistent growth in Pylarify and PET imaging over the next twelve months.
The firm expressed incremental confidence in Lantheus’s longer-term opportunity as pipeline products begin to launch in 2026, including next-generation PET imaging and Alzheimer’s-related offerings.
In other recent news, Lantheus Holdings reported its second-quarter 2025 earnings, which fell short of expectations. The company posted an adjusted earnings per share (EPS) of $1.57, missing the anticipated $1.67. Additionally, revenue was reported at $378 million, below the expected $389.14 million. This disappointing performance was attributed to competitive pricing pressure from Blue Earth Diagnostics. In response to these results, JMP Securities lowered its price target for Lantheus from $112 to $73, while maintaining a Market Outperform rating. These developments highlight the challenges Lantheus is facing in a competitive market environment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.